Tags

Type your tag names separated by a space and hit enter

Comparing the screening property of the shortened versions of the Hypomania Checklist-32 (HCL-32): Cross-validation in Korean patients with bipolar disorder and major depressive disorder.
J Affect Disord. 2018 02; 227:384-390.JA

Abstract

BACKGROUND

To date, shortened versions of the Hypomania Checklist-32 (HCL-32) were proposed to overcome the limitation of a lengthy format; however, a cross-validation study is currently needed to identify which shorter version may function optimally in a clinical sample.

METHODS

In a Korean patient sample with bipolar disorder (BD) and major depressive disorder (MDD) (BD-I n = 84, BD = II n = 145, MDD n = 285), we examined the reliability and screening property of three shorter versions of the HCL (HCL-20, -16, -8) in comparison with the full HCL-32. Diagnosis was confirmed by the structured clinical interview (SCID-I).

RESULTS

All three shortened HCLs demonstrated a fair screening ability (Area Under the Curve = .72~.74) to discriminate BD patients from MDD patients, which was comparable to that of the HCL-32. When sensitivity and specificity were considered, the HCL-20 showed relatively superior performance among the shortened versions.

LIMITATIONS

The shorter versions were not administered in a 'stand-alone' manner.

CONCLUSIONS

This is the first cross-validation study in a large clinical sample with an increased statistical power to compare the screening property of the shortened HCLs. Our results suggest that briefer versions of the HCL could be reliably and economically utilized in clinical and research settings to enhance detection of BD.

Authors+Show Affiliations

Department of Psychology, Seoul National University, Seoul, South Korea.Depression Center, Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.Aeromedical Center, Korean Air, Seoul, South Korea.Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: jihae0931.kim@samsung.com.

Pub Type(s)

Comparative Study
Journal Article
Validation Study

Language

eng

PubMed ID

29149757

Citation

Kim, Bin-Na, et al. "Comparing the Screening Property of the Shortened Versions of the Hypomania Checklist-32 (HCL-32): Cross-validation in Korean Patients With Bipolar Disorder and Major Depressive Disorder." Journal of Affective Disorders, vol. 227, 2018, pp. 384-390.
Kim BN, Lee EH, Kim HJ, et al. Comparing the screening property of the shortened versions of the Hypomania Checklist-32 (HCL-32): Cross-validation in Korean patients with bipolar disorder and major depressive disorder. J Affect Disord. 2018;227:384-390.
Kim, B. N., Lee, E. H., Kim, H. J., & Kim, J. H. (2018). Comparing the screening property of the shortened versions of the Hypomania Checklist-32 (HCL-32): Cross-validation in Korean patients with bipolar disorder and major depressive disorder. Journal of Affective Disorders, 227, 384-390. https://doi.org/10.1016/j.jad.2017.11.008
Kim BN, et al. Comparing the Screening Property of the Shortened Versions of the Hypomania Checklist-32 (HCL-32): Cross-validation in Korean Patients With Bipolar Disorder and Major Depressive Disorder. J Affect Disord. 2018;227:384-390. PubMed PMID: 29149757.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparing the screening property of the shortened versions of the Hypomania Checklist-32 (HCL-32): Cross-validation in Korean patients with bipolar disorder and major depressive disorder. AU - Kim,Bin-Na, AU - Lee,Eun-Ho, AU - Kim,Hye-Jin, AU - Kim,Ji-Hae, Y1 - 2017/11/06/ PY - 2017/04/12/received PY - 2017/09/11/revised PY - 2017/11/04/accepted PY - 2017/11/18/pubmed PY - 2018/8/29/medline PY - 2017/11/18/entrez KW - Bipolar disorder KW - HCL-32 KW - Major depressive disorder KW - Screening KW - Short form SP - 384 EP - 390 JF - Journal of affective disorders JO - J Affect Disord VL - 227 N2 - BACKGROUND: To date, shortened versions of the Hypomania Checklist-32 (HCL-32) were proposed to overcome the limitation of a lengthy format; however, a cross-validation study is currently needed to identify which shorter version may function optimally in a clinical sample. METHODS: In a Korean patient sample with bipolar disorder (BD) and major depressive disorder (MDD) (BD-I n = 84, BD = II n = 145, MDD n = 285), we examined the reliability and screening property of three shorter versions of the HCL (HCL-20, -16, -8) in comparison with the full HCL-32. Diagnosis was confirmed by the structured clinical interview (SCID-I). RESULTS: All three shortened HCLs demonstrated a fair screening ability (Area Under the Curve = .72~.74) to discriminate BD patients from MDD patients, which was comparable to that of the HCL-32. When sensitivity and specificity were considered, the HCL-20 showed relatively superior performance among the shortened versions. LIMITATIONS: The shorter versions were not administered in a 'stand-alone' manner. CONCLUSIONS: This is the first cross-validation study in a large clinical sample with an increased statistical power to compare the screening property of the shortened HCLs. Our results suggest that briefer versions of the HCL could be reliably and economically utilized in clinical and research settings to enhance detection of BD. SN - 1573-2517 UR - https://www.unboundmedicine.com/medline/citation/29149757/Comparing_the_screening_property_of_the_shortened_versions_of_the_Hypomania_Checklist_32__HCL_32_:_Cross_validation_in_Korean_patients_with_bipolar_disorder_and_major_depressive_disorder_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0165-0327(17)30753-X DB - PRIME DP - Unbound Medicine ER -